This event is archived. Final snapshot from when the story concluded. View on Dashboard
Tech genetic engineering

Colossal Biosciences Genetically Engineers Dire Wolves

Analysis based on 8 articles · First reported Apr 07, 2025 · Last updated Apr 08, 2025

Sentiment
20
Attention
2
Articles
8
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

The advancements by Colossal Biosciences in genetic engineering and cloning could open new avenues for biotechnology investments and conservation efforts. While the immediate financial market impact is limited, successful de-extinction and species conservation technologies could attract significant funding and partnerships in the long term.

biotechnology conservation

Colossal Biosciences has successfully genetically engineered three wolf pups to resemble extinct dire wolves, using CRISPR technology on gray wolf blood cells and domestic dog surrogates. These pups, aged three to six months, exhibit physical traits like long white hair and muscular jaws, aiming to reach 140 pounds at maturity. However, independent scientists like Vincent Lynch caution that this effort creates superficial resemblances and that dire wolves cannot fulfill their original ecological roles in modern landscapes. Colossal Biosciences also cloned four red wolves to increase genetic diversity in the endangered population, a less invasive technique praised by experts like Bong Go for its conservation potential. Ben Lamm, CEO of Colossal Biosciences, met with the United States — United States Department of the Interior, and Secretary Doug Burgum lauded the scientific progress.

100 Colossal Biosciences genetically engineered wolves
80 Colossal Biosciences cloned red wolves
priv
Colossal Biosciences is the company that genetically engineered wolves to resemble dire wolves and cloned red wolves, showcasing its advancements in de-extinction and conservation technologies.
Importance 100.0 Sentiment 50.0
per
Josh Shapiro, Colossal Biosciences' chief scientist, explained the genetic modification process using CRISPR technology on gray wolf blood cells.
Importance 50.0 Sentiment 0.0
per
Ben Lamm, CEO of Colossal Biosciences, mentioned meeting with officials from the U.S. Interior Department regarding the project.
Importance 50.0 Sentiment 0.0
per
Vincent Lynch, a biologist at the University at Buffalo, provides an independent scientific perspective, stating that the effort can only make animals superficially resemble extinct species and that dire wolves cannot perform their original ecological functions on today's landscapes.
Importance 40.0 Sentiment 0.0
per
Matt James, Colossal Biosciences' chief animal care expert, highlighted the limitation that the engineered pups would not learn natural hunting skills without wild dire wolf parents.
Importance 40.0 Sentiment 0.0
govactor
The United States — United States Department of the Interior met with Colossal Biosciences officials to discuss the project, with its Secretary praising the scientific advancements.
Importance 30.0 Sentiment 0.0
per
Doug Burgum, the U.S. Interior Secretary, praised Colossal Biosciences' work on X, calling it a 'thrilling new era of scientific wonder'.
Importance 30.0 Sentiment 0.0
per
Bong Go, a wildlife expert at the University of Montana, commented on the broader application of the cloning technology for conservation, noting its less invasive nature but also the challenge of sedating wild wolves.
Importance 30.0 Sentiment 0.0
cnt
Importance 0.0 Sentiment 0.0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.